| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Carisma Therapeutics Inc.
13D/A
Amendment 6
CARM · 14216R101
|
0% |
9/2/2025
Event 9/2/2025
|
|||
| HealthCap VII, L.P. | 0% | ||||
| HealthCap VII GP LLC | 0% | ||||
|
Carisma Therapeutics Inc.
13D/A
Amendment 5
CARM · 14216R101
|
4.8% |
8/29/2025
Event 8/27/2025
|
|||
| HealthCap VII, L.P. | 4.8% | ||||
| HealthCap VII GP LLC | 4.8% | ||||
|
Carisma Therapeutics Inc.
13D/A
Amendment 4
CARM · 14216R101
|
6.5% |
8/21/2025
Event 8/19/2025
|
|||
| HealthCap VII, L.P. | 6.5% | ||||
| HealthCap VII GP LLC | 6.5% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.